Literature DB >> 15968809

Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy.

Caroline Selai1, Debbie Bannister, Michael Trimble.   

Abstract

We review the literature on the influence of antiepileptic drugs (AEDs) on mood and quality of life in patients with epilepsy. Although many anecdotal reports cover a spectrum of AEDs, most of the controlled data have come from studies of carbamazepine and lamotrigine. Both of these compounds appear to have positive effects on mood, and these data parallel the effects noted in nonepilepsy populations. AEDs that are gamma-aminobutyric acid (GABA)ergic tend to have negative effects on mood, and an affective disorder is often noted as a treatment-emergent effect. It is speculated that the amygdala is an important anatomic structure in the cerebral circuits that regulate mood in affective disorders but also in epilepsy, and an effect of AEDs on such circuits aids mood stability in both populations of patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968809     DOI: 10.1111/j.1528-1167.2005.463010.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

Review 1.  Update on depression in neurologic illness: stroke, epilepsy, and multiple sclerosis.

Authors:  Richard M Sobel; Susan Lotkowski; Steven Mandel
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

2.  Prospective Cohort Study of Depression During Pregnancy and the Postpartum Period in Women With Epilepsy vs Control Groups.

Authors:  Kimford J Meador; Zachary N Stowe; Carrie Brown; Chelsea P Robalino; Abigail G Matthews; Laura A Kalayjian; P Emanuela Voinescu; Elizabeth E Gerard; Patricia Penovich; Evan R Gedzelman; Jennifer Cavitt; Page B Pennell
Journal:  Neurology       Date:  2022-08-17       Impact factor: 11.800

Review 3.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 4.  Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs.

Authors:  J Mitchell Miller; Robert P Kustra; Alain Vuong; Anne E Hammer; John A Messenheimer
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

Authors:  Cecilie Johannessen Landmark
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Postpartum depression in women with epilepsy: influence of antiepileptic drugs in a prospective study.

Authors:  Melanie Galanti; D Jeffrey Newport; Page B Pennell; Denicia Titchner; Melanee Newman; Bettina T Knight; Zachary N Stowe
Journal:  Epilepsy Behav       Date:  2009-10-23       Impact factor: 2.937

7.  A computational study of stimulus driven epileptic seizure abatement.

Authors:  Peter Neal Taylor; Yujiang Wang; Marc Goodfellow; Justin Dauwels; Friederike Moeller; Ulrich Stephani; Gerold Baier
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

8.  Stimulus-induced Epileptic Spike-Wave Discharges in Thalamocortical Model with Disinhibition.

Authors:  Denggui Fan; Suyu Liu; Qingyun Wang
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

9.  Robust closed-loop control of spike-and-wave discharges in a thalamocortical computational model of absence epilepsy.

Authors:  Yafang Ge; Yuzhen Cao; Guosheng Yi; Chunxiao Han; Yingmei Qin; Jiang Wang; Yanqiu Che
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

10.  Epilepsy and suicide: pathogenesis, risk factors, and prevention.

Authors:  Alberto Verrotti; Alessandra Cicconetti; Barbara Scorrano; Domenico De Berardis; Carla Cotellessa; Francesco Chiarelli; Filippo Maria Ferro
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.